Dermatology AdvisorRadiofrequency Microneedling: Postmarketing Data Reveals Adverse Effects

⚠️ Rare but High Risk Safety Event

Analysis of 114 MAUDE database reports spanning 2013 to 2025 identified 224 distinct adverse events associated with radiofrequency microneedling devices. Reports increased markedly after 2020, with a peak in 2023. Voluntary reporting and incomplete clinical details limit incidence estimates, but the consequences documented include permanent structural changes.

Clinical Considerations

• Textural changes were the most common adverse event at 25%, followed by pigmentary alteration (18.3%) and subcutaneous fat loss (11.6%), the latter occurring almost exclusively on the face and submental area
• Rare but serious events included neuromuscular symptoms such as transient facial weakness, muscle spasm, and dizziness (3.1%) and vascular injury (0.9%)
• Reports originated from both clinical professionals (31.6%) and consumers or patient advocates (39.5%), suggesting meaningful underreporting from clinical settings
• MAUDE data reflect voluntary submission; true adverse event frequency is likely higher than captured

Practice Applications

• Counsel patients explicitly on risk of permanent textural, pigmentary, and fat loss changes before any RFMN procedure
• Recognize that face and submental areas carry the highest fat loss risk; adjust energy settings and technique accordingly
• Monitor patients for delayed inflammatory reactions and prolonged pain beyond the expected recovery window
• Adhere to FDA-cleared indications; off-label anatomic applications carry uncharacterized risk profiles